Research Article
Adipokines and Insulin Resistance in Young Adult Survivors of Childhood Cancer
Table 4
Patients characteristics by radiotherapy (RT). Data are median and quartiles (1q; 3q) or mean ± SD.
| | | RT | Non-RT | value | | | | | | | Mean ± SD | Median (q1; q3) | Mean ± SD | Median (q1; q3) |
| | Age at study (years) | 24.65 ± 3.59 | 24.19 (22.51; 26.34) | 23.04 ± 3.11 | 22.05 (20.91; 24.98) | 0.06 | | Follow-up after treatment (years) | 12.33 ± 5.17 | 12.30 (8.1; 16.2) | 10.81 ± 5.2 | 9.8 (6.55; 14.6) | 0.23 | | BMI (kg/m2) | 23.79 ± 3.93 | 23.16 (20.80; 26.01) | 23.79 ± 4.26 | 22.73 (20.89; 26.41) | 0.74 | | WHR | 0.85 ± 0.14 | 0.81 (0.77; 0.92) | 0.84 ± 0.12 | 0.83 (0.74; 0.91) | 0.39 | | FAT (%) | 28.2 ± 11.3 | 28.5 (17.9; 37) | 25.0 ± 8.10 | 21.7 (20.0; 31.8) | 0.37 | | Lean (g) | 48974 ± 9846 | 46740 (40849; 56463) | 53566 ± 1050 | 55754 (46193; 60926) | 0.11 | | Lean/FAT | 3.07 ± 1.95 | 2.36 (1.59; 4.32) | 3.26 ± 1.39 | 3.42(2.03; 3.79) | 0.35 | | Insulin (IU/mL) | 10.2 ± 18.0 | 6.10 (3.33; 11.6) | 8.00 ± 5.10 | 6.97 (4.15; 9.48) | 0.85 | | Glucose (mmol/L) | 0.49 ± 0.09 | 0.49 (0.46; 0.54) | 0.50 ± 0.04 | 0.49 (0.47; 0.52) | 0.58 | | HOMA-IR | 0.26 ± 0.61 | 0.13 (0.06; 0.25) | 0.19 ± 0.14 | 0.16 (0.10; 0.24) | 0.51 | | Adiponectin (ng/mL) | 8395 ± 5440 | 6026 (4529; 10073) | 6873 ± 5247 | 4855 (4223; 7466) | 0.35 | | Adiponectin/FAT in gram | 0.46 ± 0.36 | 0.34 (0.25; 0.60) | 0.36 ± 0.33 | 0.26 (0.17; 0.35) | 0.15 | | Leptin (pg/mL) | 11499 ± 14382 | 5461 (1689; 18568) | 8319 ± 6736 | 6463 (2747; 14093) | 0.80 | | Leptin/FAT in gram | 0.68 ± 1.24 | 0.40 (0.09; 0.79) | 0.41 ± 0.31 | 0.33 (0.15; 0.65) | 0.61 | | Leptin/adiponectin ratio | 1.93 ± 3.00 | 0.60 (0.24; 1.92) | 1.95 ± 2.66 | 1.02 (0.37; 2.87) | 0.42 | | Resistin (ng/mL) | 9.30 ± 3.67 | 8.77 (6.45; 11.41) | 9.35 ± 2.80 | 8.85 (7.30; 10.63) | 0.70 |
|
|
